Progesterone soft gelatin capsules can be taken from vaginal riute
Reading File
Searching the Web
progesterone soft gelatin capsules vaginal route administration clinical use
Finding Sources
Searching PubMed
progesterone vaginal capsule soft gelatin oral capsule
Reading File
Reading File
Yes, absolutely. Here is a detailed explanation:
Progesterone Soft Gelatin Capsules - Vaginal Route
Can oral soft gelatin capsules be used vaginally?
Yes. Micronized progesterone soft gelatin capsules (e.g., Utrogestan 200 mg, Susten, Prome, Gestofit) are routinely inserted vaginally, even though they are manufactured as oral capsules. This is an accepted, well-documented off-label (or sometimes on-label, depending on the brand/country) practice in clinical medicine.
Why the Vaginal Route is Preferred Over Oral
The pharmacological rationale is well established (from Creasy & Resnik's Maternal-Fetal Medicine):
-
"Uterine first-pass effect" - Vaginally administered progesterone results in relatively lower serum progesterone but higher endometrial/uterine progesterone concentrations compared to other routes. This is due to direct absorption through the vaginal mucosa to the uterus via a counter-current vascular mechanism.
-
Avoids hepatic first-pass metabolism - Oral progesterone undergoes extensive first-pass metabolism in the liver, which:
- Reduces bioavailability
- Generates neuroactive metabolites (causing sedation, dizziness)
- Increases side effects
-
Better target organ delivery - For uterine indications, the vaginal route delivers more drug directly to the uterus with fewer systemic side effects.
Clinical Indications for Vaginal Progesterone Soft Gelatin Capsules
| Indication | Dose |
|---|---|
| Luteal phase support (IVF/ART) | 200-400 mg/day vaginally |
| Prevention of preterm birth (short cervix/prior PTB) | 200 mg/day vaginally |
| Threatened miscarriage / early pregnancy support | 200-400 mg/day vaginally |
| HRT - endometrial protection | 200 mg vaginally every night |
| Secondary amenorrhea | 200 mg vaginally |
How to Insert
- The capsule is inserted high into the vagina (posterior fornix), ideally at bedtime
- The gelatin shell dissolves, releasing micronized progesterone
- A waxy/white vaginal discharge is common and expected (excipient residue - this is normal)
- Lying down after insertion (bedtime use) helps reduce leakage
Key Pharmacokinetic Difference: Oral vs. Vaginal
| Parameter | Oral Route | Vaginal Route |
|---|---|---|
| Serum progesterone | Higher | Lower |
| Uterine/endometrial progesterone | Lower | Higher |
| Hepatic first-pass | Yes (significant) | Avoided |
| Sedation/drowsiness | Common | Minimal |
| Bioavailability | ~10% | ~50-80% (target organ) |
Summary
Progesterone soft gelatin capsules inserted vaginally are a standard clinical practice backed by strong pharmacokinetic and clinical trial evidence. The vaginal route is actually preferred over the oral route for most uterine indications because of the uterine first-pass effect and avoidance of liver metabolism. This is documented across reproductive medicine, maternal-fetal medicine, and menopause management guidelines.
- Creasy & Resnik's Maternal-Fetal Medicine, Chapter on Preterm Birth Prevention (Pharmacology section)
This is a shared conversation. Sign in to Orris to start your own chat.